Stay updated on Tuspetinib in AML: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tuspetinib in AML: Safety & Efficacy Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the page header.
    Difference
    0.0%
    Check dated 2026-04-16T11:15:30.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.3 to v3.5.0 on the page, reflecting a platform update.
    Difference
    0.0%
    Check dated 2026-03-18T19:19:13.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page metadata now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T17:49:28.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-11T02:40:41.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status, with guidance to visit cc.nih.gov and opm.gov for updates. Updated the page's release notes from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T01:38:01.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page now includes a 'Show glossary' option and updated study record date labels such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted', with older labels removed or updated. Footer metadata has been updated to include 'No FEAR Act Data' and 'Revision: v3.4.0', while 'No FEAR Act data' and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-27T23:13:21.000Z thumbnail image

Stay in the know with updates to Tuspetinib in AML: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.